Print Page   |   Contact Us   |   Your Cart   |   Sign In
Search
Sign In


Forgot your password?

Haven't registered yet?

Breaking News
Calendar
HIV Vaccine Research

HIV Vaccine Research

 OVERVIEW  | REGULATIONS & GUIDELINES | BEST PRACTICES | INSTRUCTIONAL RESOURCES | PATIENT RESOURCES  


Overview             

NIAID HIV/AIDS Research Program

Although progress has been made in the global fight against HIV/AIDS, the epidemic continues to devastate the United States and the international community with an average of 50,000 new HIV infections each year in the United States and an estimated 33 million people living with HIV worldwide. As the leading U.S. government institute for HIV/AIDS research, NIAID is committed to conducting the research necessary to successfully end the fight against HIV/AIDS.

Through laboratories and clinics on the National Institutes of Health campus in Bethesda, Maryland, and a vast network of supported research at universities, medical centers, and clinical trial sites around the globe, NIAID is working to better understand HIV and how it causes disease, find new tools to prevent HIV infection including a preventive vaccine, develop new and more effective treatments for people infected with HIV, and hopefully, find a cure.

Source: NIH-NIAID

Back to Top

Regulations & Guidelines                     

NIH

HIV Vaccine Research

AIDS.gov

Vaccines 

WHO

WHO-UNAIDS HIV Vaccine Initiative

Back to Top

 

Best Practices                  
Key Learnings as of July 2015

Vaccines teach the immune system to recognize a specific harmful organism and fight off the disease when the body faces the real thing. Despite extraordinary advances in understanding both HIV and the human immune system, a fully successful HIV vaccine continues to elude researchers. More...

Related Articles

 MedlinePlus - HIV Vaccine

Back to Top

 

Instructional Resources                  
Fact Sheets

History of HIV Vaccine Research

Back to Top

 

Patient Resources               

(1) Answers about HIV vaccine research

(2) Global HIV Vaccine Enterprise

       

 

OSAP Disclaimer | Please notify ourwebmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2015. Sponsorship does not imply endorsement by OSAP of a company's products or services.